No Barrier
Instant AI Medical Interpreting at the Point of Care
Company Overview
Snapshot
Founded in June 2025 by Eyal Heldenberg and Moe Abramovitch, No Barrier operates with 1–10 employees. The company has secured funding across one round from two investors, including Esplanade Healthcare Ventures and A-Squared Ventures. No Barrier is developing an AI medical interpreter for healthcare providers.
Business overview
No Barrier develops an AI medical interpreter designed for hospitals, clinics, and healthcare networks. Its core technology provides real-time speech-to-speech interpretation, enabling instant communication between healthcare providers and Limited English Proficiency (LEP) patients. The platform is HIPAA compliant, built for clinical accuracy, and incorporates safety controls, such as easy escalation to a human interpreter when necessary. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Patient Engagement, targeting healthcare providers.
Company Intelligence Q&A
- When was No Barrier founded?
- No Barrier was founded in June 2025.
- Who are the founders of No Barrier?
- No Barrier was founded by Eyal Heldenberg and Moe Abramovitch.
- What is No Barrier's primary focus?
- No Barrier focuses on providing instant AI medical interpreting at the point of care for hospitals, clinics, and healthcare networks.
- What is the core technology behind No Barrier's solution?
- No Barrier utilizes AI to deliver real-time speech-to-speech interpretation, ensuring HIPAA compliance and clinical accuracy.
- Which investors participated in No Barrier's funding round?
- In June 2025, No Barrier received funding from Esplanade Healthcare Ventures and A-Squared Ventures.